Active

Follistatin plasmid gene therapy (N-of-1)

Status: Active Intervention: Follistatin plasmid Not an XPRIZE trial

Documented participation in an experimental follistatin approach, with baseline and follow-up measures (including body composition and performance markers). This is not part of any XPRIZE trial.

Results are shared on a predefined schedule — positive, negative, mixed, or inconclusive — without protocol recommendations.

Read the follistatin article →
How these experiments are framed
These are personal N-of-1 experiments, not clinical trials. Results do not establish efficacy for other people. Positive, negative, mixed, and inconclusive outcomes will be reported. Financial or in-kind relationships will be disclosed. Published only at predefined milestones. No protocol guidance.

Related

The 2027 Younger Experiment

A separate, six-month measured protocol I am preparing to enter. It lives on its own page so sponsorship conversations stay distinct from this overall N-of-1 framework.

Younger 2027 →

Context

Why this sits under the work — not on top of it

The primary editorial product is independent coverage of longevity claims and trials. Personal experiments are a parallel track: useful for transparency and questions the literature doesn’t answer yet, never a substitute for controlled evidence.